Maa Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.75 Cr
as on 04-12-2024
- Paid Up Capital ₹ 2.42 Cr
as on 04-12-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 6.91 Cr
as on 04-12-2024
- Revenue 27.65%
(FY 2019)
- Profit -87.83%
(FY 2019)
- Ebitda -729.19%
(FY 2019)
- Net Worth -54.29%
(FY 2019)
- Total Assets -85.32%
(FY 2019)
About Maa Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.75 Cr and a paid-up capital of Rs 2.42 Cr.
The company has closed loans amounting to ₹6.91 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Malla Madireddy, Muralidhar Rambathri, Hema Rambathri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC069157
- Company No.
069157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2010
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maa Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhar Rambathri  | Managing Director | 29-Dec-2012 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malla Madireddy | Whole-Time Director | 13-Aug-2016 | Current |
| Hema Rambathri | Director | 29-Dec-2012 | Current |
| Sanjeeva Guduru | Director | 13-Aug-2016 | Current |
| Shivaranjini Kannayya | Director | 08-Aug-2015 | Current |
Financial Performance of Maa Laboratories.
Maa Laboratories Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 27.65% increase. The company also saw a substantial fall in profitability, with a 87.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maa Laboratories?
In 2019, Maa Laboratories had a promoter holding of 80.02% and a public holding of 19.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Indur Life Sciences Private LimitedActive 13 years 9 months
Muralidhar Rambathri and Hema Rambathri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Aug 2014 | ₹6.91 Cr | Satisfied |
How Many Employees Work at Maa Laboratories?
Maa Laboratories has a workforce of 38 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maa Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maa Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
